Jeff Yass’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-58,674
Closed -$6K 13157
2020
Q4
$6K Buy
58,674
+47,998
+450% +$2.97K ﹤0.01% 10931
2020
Q3
$1K Sell
10,676
-13,506
-56% -$1.21K ﹤0.01% 10461
2020
Q2
$2K Buy
+24,182
New +$2.02K ﹤0.01% 10017
2020
Q1
Sell
-42,467
Closed -$2K 11184
2019
Q4
$2K Sell
42,467
-46,154
-52% -$1.08K ﹤0.01% 9592
2019
Q3
$2K Buy
88,621
+450
+0.5% +$32 ﹤0.01% 10063
2019
Q2
$16K Hold
88,171
﹤0.01% 10032
2019
Q1
$5K Buy
+88,171
New +$11.2K ﹤0.01% 8678
2018
Q1
Sell
-173,112
Closed -$61K 10535
2017
Q4
$61K Hold
173,112
﹤0.01% 8858
2017
Q3
$68K Hold
173,112
﹤0.01% 8468
2017
Q2
$78K Hold
173,112
﹤0.01% 8789
2017
Q1
$145K Hold
173,112
﹤0.01% 8224
2016
Q4
$107K Buy
+173,112
New +$155K ﹤0.01% 9051

Other funds holding ONTXW

Jeff Yass's ONTXW Position: Q1 2021 in Review

Jeff Yass sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q1 2021, closing a stake of 58,674 shares — an estimated $6K sold.

Jeff Yass first reported a position in ONTXW in Q4 2016 and held it in 12 quarters. The position peaked at $145K in Q1 2017. 2 funds tracked by Wall St. Rank hold ONTXW as of Q1 2021.

  • Jeff Yass reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q1 2021 after selling out during the quarter.
  • Jeff Yass sold 58,674 Onconova Therapeutics, Inc. Warrants shares in Q1 2021, an estimated $6K.
  • Jeff Yass first reported a position in Onconova Therapeutics, Inc. Warrants in Q4 2016 and held it in 12 quarters.
  • Jeff Yass's Onconova Therapeutics, Inc. Warrants position peaked at $145K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.